Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 26Genitourinary 22Gastrointestinal 21Thoracic 18Sarcoma 10Dermatologic 10Head & Neck 7Other solid neoplasm 5Gynecologic 3CNS 3Lymphoid 2Tumor-Agnostic 1Other hematologic neoplasm 1NET 1Endocrine 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 1Ovarian Neoplasms 1

Interventions

Paclitaxel 268Carboplatin 264Cisplatin 194Bevacizumab 135pembrolizumab 99Surveys and Questionnaires 84Radiotherapy 77Cyclophosphamide 75olaparib 67Blood Specimen Collection 65Drug Therapy 62Hyperthermic Intraperitoneal Chemotherapy 60Gemcitabine 60niraparib 56Topotecan 56Brachytherapy 54liposomal doxorubicin 52Taxes 47Docetaxel 46Magnetic Resonance Spectroscopy 43Letrozole 36Cytoreduction Surgical Procedures 36Filgrastim 33Biopsy 33Surgical Procedures, Operative 32durvalumab 31Specimen Handling 31Doxorubicin 31Nivolumab 30Albumin-Bound Paclitaxel 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Cryosurgery × Gynecologic × Clear all
NCT02849340 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02849353 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Gynecologic

Ovarian Neoplasms

NCT00233727 2015-07-09

SAT

Columbia University

Phase 3 Terminated
7,123 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡